Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Bcr protein

Like many other nonreceptor tyrosine kinases, Abl tyrosine kinase may be converted by mutations into a dominant oncoprotein and thus contribute to tumor formation. Abl tyrosine kinase was first discovered as the oncogene of murine Abelson leukemia virus. Chronic myelogenic leukemia in humans is cause by a chromosome translocation in which a fusion protein is created of Abl tyrosine kinase and a Bcr protein (c Chapter 14). The result is a greatly increased tyrosine kinase activity, to which a causal role in occurrence of this leukemia is attributed. [Pg.312]

Inhibition of hematopoietic growth factors Imatinib (Glivec ) is applied to treat chronic myeloid leukemia in Philadelphia-chromosome positive patients. In these patients, translocation of parts of chromosomes 9 and 22 results in the expression of a fusion protein with increased tyrosine kinase activity, called Bcr-Abl. Imatinib is a small Mw inhibitor selective for the tyrosine kinase activity of Bcr-Abl. Thereby, it inhibits the Bcr-Abl induced cell cycle progression and the uncontrolled proliferation of tumor cells. [Pg.411]

In chronic myelogenous leukemia (CML) as well as in a subset of acute lymphoblastic leukemia (ALL) Bcr-Abl, a fusion protein of c-Abl and the breakpoint cluster region (bcr), is expressed in the cytosol of leukemic cells. This fusion protein forms homo-oligomeric complexes that display elevated kinase activity and is the causative molecular abnormality in CML and certain ALL. The transforming effect of Bcr-Abl is mediated by numerous downstream signaling pathways, including protein kinase C (PKC), Ras-Raf-ERK MAPK, JAK-STAT (see below), and PI3-kinase pathways. [Pg.1260]

Gleevec ) is a tyrosine kinase inhibitor used as first-line therapy in the majority of patients with CML. As a potent tyrosine kinase inhibitor, imatinib inhibits phosphorylation of various proteins involved in cell proliferation. Imatinib works by binding to the ATP-binding pocket of BCR-ABL.7 The drug induces complete hematologic responses in more than 95% of patients and complete cytogenetic responses in about 80% of patients in chronic phase.8 Most patients have traces of the disease when measured by RT-PCR and are not cured of their disease. [Pg.1417]

In B lymphocytes, coupling of the antigen receptors to Erk MAPkinase is protein tyrosine kinase (PTK)-dependent (Pao et al, 1997). Following ligation of the BCR (Fig. 19.2) the PTK, Lyn, tyrosine phosphorylates the immunoreceptor tyrosine-based activation motifs (ITAMs) on the accessory transducing molecules Ig-a and Ig-(3, leading to the recruitment... [Pg.411]

Keywords Tyrphostins, Protein tyrosine, Kinases, JAK-2 EGF, PDGF BCR-ABL, Psoriasis, Papilloma, Restenosis, Leukemia, Lymphoma... [Pg.2]

A well-known use of molecular methods is in the study of chromosomal translocations. Thus, in Philadelphia chromosome (ph1) positive chronic myelogenous leukemia (CML), the C-abl oncogene on chromosome 9 is translocated to a region on chromosome 22 called the breakpoint cluster region, or bcr. This (t9 22) translocation results in production of an abnormal fusion protein... [Pg.31]

Thymus-derived, or T, lymphocytes also have an immunoglobulin-like surface receptor linked with accessory proteins to form the T-cell receptor (TCR). There are similarities between the BCR and TCR in that the recognition part of the T receptor complex is also a dimer. In most T cells, the dimer consists of a and [3 individual peptide... [Pg.156]


See other pages where Bcr protein is mentioned: [Pg.340]    [Pg.567]    [Pg.328]    [Pg.329]    [Pg.372]    [Pg.320]    [Pg.461]    [Pg.115]    [Pg.26]    [Pg.340]    [Pg.567]    [Pg.328]    [Pg.329]    [Pg.372]    [Pg.320]    [Pg.461]    [Pg.115]    [Pg.26]    [Pg.156]    [Pg.250]    [Pg.255]    [Pg.570]    [Pg.1012]    [Pg.1012]    [Pg.1177]    [Pg.1194]    [Pg.1256]    [Pg.1257]    [Pg.1261]    [Pg.1487]    [Pg.163]    [Pg.209]    [Pg.216]    [Pg.56]    [Pg.1399]    [Pg.248]    [Pg.266]    [Pg.412]    [Pg.413]    [Pg.413]    [Pg.147]    [Pg.5]    [Pg.12]    [Pg.517]    [Pg.518]    [Pg.49]    [Pg.50]    [Pg.57]    [Pg.157]    [Pg.446]   
See also in sourсe #XX -- [ Pg.372 ]




SEARCH



BCR-ABL Fusion Protein

BCR-ABL protein

© 2024 chempedia.info